A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain

Clinical trial NCT01439919 · TERMINATED

Trial details

NCT number: NCT01439919
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pain Breakthrough Cancer Pain

Start date: 2012-01-01
Primary completion: 2012-02-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.